Numerical indices based on circulating tumor DNA for the evaluation of therapeutic response and disease progression in lung cancer patients

Kikuya Kato(Nara Institute of Science and Technology), Fumio Imamura(Osaka International Cancer Institute)

Scientific Reports

July 6, 2016

10.1038/srep29093

Cited by 17

Related Papers

Monitoring gastric cancer progression with circulating tumour DNA

|British Journal of Cancer|2014|103

High-fidelity target sequencing of individual molecules identified using barcode sequences:<i>de novo</i>detection and absolute quantitation of mutations in plasma cell-free DNA from cancer patients

|DNA Research|2015|88

Analytical Performance of a Highly Sensitive System to Detect Gene Variants Using Next-Generation Sequencing for Lung Cancer Companion Diagnostics

|Diagnostics|2023|26

Early responses of <i>EGFR</i> circulating tumor DNA to EGFR tyrosine kinase inhibitors in lung cancer treatment

|Oncotarget|2016|22

Selective identification of somatic mutations in pancreatic cancer cells through a combination of next-generation sequencing of plasma DNA using molecular barcodes and a bioinformatic variant filter

|PLoS ONE|2018|17